FGF-2 converts mature oligodendrocytes to a novel phenotype

Journal of Neuroscience Research

Volumn 50, Issue 2, 1997, Pages 215-228

  Bansal, Rashmi ^a   Pfeiffer, S E ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

FGF; Myelin; Oligodendrocyte

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; MYELIN;

ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; ENVIRONMENTAL FACTOR; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MITOSIS; OLIGODENDROGLIA; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; STEM CELL;

ANIMALS; CELL AGING; CELL CYCLE; CELLS, CULTURED; DOWN-REGULATION; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; MITOSIS; MYELIN SHEATH; OLIGODENDROGLIA; PHENOTYPE; RATS; RECEPTORS, FIBROBLAST GROWTH FACTOR;

EID: 0030781924     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19971015)50:2<215::AID-JNR10>3.0.CO;2-7     Document Type: Article

References (80)

1. Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois-Dalcq ME (1992): Pre-oligodendrocytes from adult human CNS, J Neurosci 12:1538-1547.
2. Asai T, Wanaka A, Kato H, Masana Y, Seo M, Tohyama M (1993): Differential expression of two members of FGF receptor gene family, FGFR-1 and FGFR-2 mRNA, in the adult rat central nervous system. Mol Brain Res 17:174-178.
3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (1991): "Current Protocols in Molecular Biology." New York: John Wiley and Sons.
4. Bansal R, Pfeiffer SE (1989): Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids. Proc Natl Acad Sci USA 86:6181-6185.
5. Bansal R, Warrington, AE, Gard AL, Ranscht B, Peiffer SE (1989): Multiple and novel specificities of monoclonal antibodies 01, 04, and R-mAB used in the analysis of oligodendrocyte development. J Neurosci Res 24:548-557.
6. Bansal R, Pfeiffer R (1992): Novel stage in the oligodendrocyte lineage defined by reactivity of progenitors with R-mAb prior to O1 anti-galactocerebroside. J Neurosci Res 32:309-316.
7. Bansal R, Pfeiffer SE (1994): Inhibition of protein and lipid sulfation in oligodendrocytes blocks biological responses tot FGF-2 and retards cytoarchitectural maturation, but not developmental lineage progression. Dev Biol 162:511-524.
8. Bansal R, Stefansson K, Pfeiffer SE (1992): Proligodendroblast antigen (POA), a developmental antigen expressed by A007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem 58:2221-2229.
9. Bansal R, Kumar M, Murray K, Morrison R, Pfeiffer S (1996a): Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci 7:263-275.
10. Bansal R, Kumar M, Murray K, Pfeiffer S (1996b): Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes. Mol Cell Neurosci 7:276-288.
11. Basilico C, Moscatelli D (1992): The FGF family of growth factors and oncogenes. Adv. Cancer Res 59:115-163.
12. Bernier L, Alverez F, Norgard EM, Raible DW, Mentaberry A, Schembri JG, Sabatini DD, Colman DR (1987): Molecular cloning of a 2′,3′-cyclic nucleotide 3′-phosphohydrodiesterase: mRNAs with different 5′ ends encode the same set of proeins in nervous and lymphoid tissues. J Neurosci 7:2703-2710.
13. Bögler O, Wren D, Barnett SC, Land H, Noble M (1990): Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc. Natl Acad Sci USA 87:6368-6372.
14. Butt AM, Tutton MG, Kirvell SL, Amor S, Jenkins HG (1996): Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus. Neuropath Applied Neurobiol 22:540-547.
15. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
16. Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, Suzuki K, Popko B (1996): Myelination in the absence of galactocerebroside and sulfatide: Normal structure with abnormal function and regional instability. Cell 86:209-219.
17. Colvin J, Bohne B, Harding G, McEwen D, Ornitz D (1996): Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet 12:390-397.
18. Coulier F, Pontarotti P, Roubin R, Hartung H, Goldfarb M, Birnbaum D (1997): Of worms and men: An evolutionary perspective on the fibroblast growth factor (FGF) and FGF receptor families. J Mol Evol 44:43-56.
19. Dahl D, Bignami A (1974): Heterogeneity of the glial fibrillary protein in gliosed human brains. J Neurol Sci 23:551-563.
20. Deloume JC, Janet T, Pettman B, Laeng P, Knoetzen M-F, Sensenbrenner M, Baudier J (1992): Phosphorylation of the MARKS protein (p87), a major protein kinase C substrate, is not an obligatory step in the mitogenic signaling pathway of basic fibroblast growth factor in rat oligodendrocytes. J Neurochem 58:567-578.
21. Deloume JC, Laeng P, Janet T, Sensenbrenner M, Baudier J (1993): Expression of neuromodulin (GAP-43) and its regulation by biasic fibroblast growth factor during the differentiation of O-2A progenitor cells. J Neurosci Res 36:147-162.
22. Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P (1996): Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84:911-921.
23. Doherty P, Walsh F (1996): CAM-FGF receptor interactions - a model for axonal growth. Mol Cell Neurosci 8:99-111.
24. Eckenstein FP (1994): Fibroblast growth factors in the nervous system. J Neurobiol 11:1467-1480.
25. Eisenbarth GS, Walsh FS, Nirenberg M (1979): Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci USA 76:4913-4917.
26. Frank E, Ragel B (1995): Cortical basic fibroblast factor expression after head injury: Preliminary results. Neurol Res 17:129-131.
27. Fressinaud C, Laeng P, Labourdette G, Durand J, Vallat JM (1993): The proliferation of mature oligodendrocytes in vitro is stimulated by basic fibroblast growth factor and inhibited by oligodendrocyte-type 2 astrocyte precursors. Dev Biol 158:317-329.
28. Fressinaud C, Vallet JM, Labourdette G (1995): Basic fibroblast growth factor down-regulates myelin basic protein gene expression and alters myelin compaction of mature oligodendrocytes in vitro. J Neurosci Res 40:285-293.
29. Gard AL, Pfeiffer SE (1989): Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: Myelinogenic potential in defined environment. Development 106:119-132.
30. - oligodendrocyte progenitors. Dev Biol 159:618-630.
31. -) directly from postnatal rodent brain. Neuroprotocols 2:209-218.
32. Giordano S, Sherman I, Lyman W, Morrison R (1992): Multiple molecular weight forms of basic fibroblast growth factor are developmentally regulated in the central nervous system. Dev Biol 152:293-303.
33. Gogate N, Verma L, Zhou JM, Milward E, Rusten R, O'Connor M, Kufta C, Kim J, Hudson L, Dubois-Dalc M (1994): Plasticity in the adult human Oligodendrocyte lineage. J Neurosci 14:4571-4587.
34. Gomez-Pinilla F, Lee JW, Cotman CW (1992): Basic FGF in adult rat brain: Cellular distribution and response to entorhinal lesion and timbria-bornix transection. J Neurosci 12:345-355.
35. Gonzalez AM, Berry M, Maher PA, Logan A, Baird A (1995): A comprehensive analysis of the distribution of fgf-2 and fgf-1 in the rat brain. Brain Res 701:201-226.
36. Grinspan JB, Franceschini B (1995): PDGF is a survival factor for PSA-NCAM+ oligodendroglial pre-progenitor cells. J Neurosci Res 41:540-551.
37. Grinspan JB, Stern JL, Franceschini B, Pleasure D (1993): Trophic effect of basic fibroblast growth factor (bFGF) on differentiated oligodendroglia: A mechanism for regeneration of the oligodendroglial lineage. J Neurosci Res 36:672-690.
38. Grinspan JB, Reeves MF, Coulaloglou MJ, Nathanson D, Pleasure D (1996): Re-entry into the cell cycle is required for bFGF-induced oligodendroglial dedifferentiation and survival. J Neurosci Res 46:456-464.
39. Hoffman KL, Duncan ID (1995): Canine oligodendrocytes undergo morphological changes in response to basic fibroblast growth factor (bFGF) in vitro. Glia 14:33-42.
40. Johnson DE, Williams LT (1993): Structural and functional diversity in the FGF receptor multigene family. Adv Cancer Res 60:1-41.
41. Koshinaga M, Sanon HR, Whittemore SR (1993): Altered acidic and basic fibroblast growth factor expression following spinal cord injury. Exp Neurol 120:32-48.
42. Kuzis K, Read S, Herry NJ, Woodward WR, Eckenstein FP (1995): Developmental time course of acidic and basic fibroblast growth factors expression in distinct cellular populations of the rat central nervous system. J Comp Neurol 358:142-153.
43. Liu HM, Chen HH (1994): Correlation between fibroblast growth factor expression and cell proliferation in experimental brain infarct: Studied with proliferating cell nuclear antigen immunohistochemistry. J Neuropathol Exper Neurol 53:118-126.
44. Logan A (1988): Elevation of acidic fibroblast growth factor in lesioned rat brain. Mol Cell Endocrinol 58:275-278.
45. Lotan M, Schwarz M (1992): Post injury changes in platelet derived growth factor-like activity in fish and rat optic nerves: Possible implications in regeneration. J Neurochem 58:1637-1642.
46. Madison DL, Krüger WH, Kim T, Pfeiffer S (1996): Differential expression of rab3 isoforms in oligodendrocytes and astrocytes. J Neurosci Res 45:258-268.
47. Mansukhani A, Dell'Era P, Moscatelli D, Kornbluth S, Hanfusa H, Basilico C (1992): Characterization of the murine BEK fibroblast growth factor (FGF) receptor: Activation by three members of the FGF family and requirement for heparin. Proc Natl Acad Sci USA 89:3305-3309.
48. Matsuyama A, Iwata H, Okumura N, Yoshida S, Imaizumi K, Lee Y, Shiraishi S, Shiosaka S (1992): Localization of basic fibroblast growth factor-like immunoreactivity in the brain. Brain Res 587:49-65.
49. Mayer M, Bögler O, Noble M (1993): The inhibition of oligodendrocytic differentiation of O-2A progenitors caused by basic fibroblast growth factor is overriden by astrocytes. Glia 8:12-19.
50. McCarthy KD, DeVellis J (1980): Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85:890-902.
51. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA (1990): FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603-614.
52. Migdal M, Shay S, Yarden Y, Neufeld G (1995): Activation of a transfected FGFR-1 receptor in Madin-Darby epithelial cells results in a reversible loss of epithelial properties. J Cell Physiol 162:266-276.
53. Milner R, Lai C, Nave K, Lenoir D, Ogata J, Sutcliffe JG (1985): Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell 42:931-939.
54. Milner R, Anderson HJ, Rippon RF, McKay JS, Franklin RJM, Marchionni MA, Reynolds R, fftench-Constant C (1997): Contrasting effects of milogenic growth factors on oligodendrocyte precursor migration. Glia 19:85-90.
55. Miyake A, Hattori Y, Ohta M, Itoh N (1996): Rate oligodendrocytes and astrocytes preferentially express fibroblast growth factor receptor-2 and -3 mRNAs. J Neurosci Res 45:534-541.
56. Muenke M, Schell U (1995): Fibroblast-growth-factor receptor mutations in human skeletal disorders. Trends Genet 11:308-313.
57. Muir DA, Compston DAS (1996): Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J Neurosci Res 44:1-11.
58. Nieko-Sampedro M, Lim R, Hicklin DJ, Cotman CW (1988): Early release of glia maturation factor and acidic fibroblast growth factor after rat brain injury. Neurosci Lett 86:361-365.
59. Norton WT (1996): Do oligodendrocytes divide? Neurochem Res 21:495-503.
60. Oh LYS, Yong VW (1996): Astorcytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix. Glia 17:237-253.
61. Ornitz DM, Leder P (1992): Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3. J Biol Chem 23:16305-16311.
62. Osterhaut DJ, Ebner S, Kane-Goldsmith N, Xu J, Ornitz DM, Zazanis GA, McKinnon RD (1997): Transplanted oligodendrocyte progenitor cells expressing a dominant-negative FGF receptor transgene fail to migrate in vivo. J Neurosci, submitted.
63. Partanen J, Mäkelä TP, Eerola E, Korhonen J, Hirvonen H, Claesson-Welsh L, Alitalo K (1991): FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 6:1347-1354.
64. Pfeiffer SE, Warrington AE, Bansal R (1993): The oligodendrocyte and its many cellular processes. Trends Cell Biol 3:191-197.
65. Prineas JW, Barnard RO, Kwon EE, Sharer L, Cho EE (1993): Multiple sclerosis. Remyelination of nascent lesions. Ann Neurol 33:137-151.
66. Raine CS, Wu E (1993): Multiple sclerosis: Remyelination in acute lesions. J Neuropath Exp Neurol 52:199.
67. Rapraeger AC, Krufka A, Olwin B (1991): Requirement of heparan sulfate for bFGF-medicated fibroblast growth and myogenic differentiation. Science 252:1705-1708.
68. Reynolds R, Hardy R (1997): Oligodendroglial progenitors labeled with the O4 antibody persist in the adult rat cerebral cortex in vivo. J Neurosci Res 47:455-470.
69. Saavedru RA, Fors L, Aebersold RH, Arden B, Horvath S, Sander J, Hood L (1989): The myelin proteins of the shark brain are similar to the myelin proteins of the mammalian peripheral nervous system. J Mol Evol 29:149-156.
70. Scolding NJ, Rayner PJ, Sussman J, Shaw, Compston DAS (1995): A proliferative adult human oligodendrocyte progenitor. NeuroReport 6:441-445.
71. Sensenbrenner M (1993): The neurotrophic activity of fibroblast growth factors. Prog Neurobiol 41:683-704.
72. Singh H, Pfeiffer SE (1985): Myelin associated galactolipids in primary cultures of dissociated fetal rat oligodendrocytes. J Neurochem 45:1371-1381.
73. Sommer I, Schachner M (1981): Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83:311-327.
74. Takami K, Kiyota Y, Iwane M, Miyamoto M, Tsukuda R, Igarashi K, Shino A, Wanaka A, Shiosaka S, Tohyama M (1993): Upregulation of fibroblast growth factor-receptor messenger RNA expression in rat brain following transient forebrain ischemia. Exp Brain Res 97:185-194.
75. Thomas D, Caruelle J-P, Lachapelle F, Barritault D, Boully B (1991): Acidic fibroblast growth factor in normal, injured and jimpy mutant developing mouse brain. Ann NY Acad Sci 648:161-166.
76. Warrington AE, Pfeiffer SE (1992): Proliferation and differentiation of 04+ oligodendrocytes in postnatal rat cerebellum: Analysis in unfixed tissue slices using anti-glycolipid antibodies. J Neurosci Res 33:338-353.
77. Wolswijk G, Noble M (1989): Identification of an adult-specific glial progenitor cell. Development 105:387-400.
78. Wood PM, Bunge RP (1986): Evidence that axons are mitogenic for oligodendrocytes isolated from adult animals. Nature 320:756-758.
79. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM (1991): Cell surface, heparin-like molecules are required for biding of basic fibroblast growth factor to its high affinity receptor. Cell 64:841-848.
80. Yazaki N, Hosoi Y, Kawabata K, Miyake A, Minami M, Satoh M, Ohta M, Kawasaki T, Itoh N (1994): Differential expression patterns of mRNAs for members of the fibroblast growth factor receptor family, FGFR-1-FGFR-4, in rat brain. J Neurosci Res 37:445-452.